NR2E3

NR2E3 (nuclear receptor subfamily 2, group E, member 3) is a member of the nuclear receptor superfamily of transcription factors. It encodes a protein of 498 amino acids that functions as a DNA‑binding transcriptional regulator. The NR2E3 gene is located on chromosome 15q15.1 in humans. A conserved ligand‑binding domain and a DNA‑binding domain containing two zinc‑finger motifs are present.

The protein is highly expressed in the retina, specifically in photoreceptor cells. It acts as a transcriptional repressor of rod‑specific genes in developing photoreceptors, while activating cone‑specific genes. NR2E3 regulates the balance between rod and cone photoreceptor development by repressing cone gene expression during rod maturation and by influencing the transcription of genes such as OPN1MW, OPN1LW, and RHODOPSIN.

Mutations in NR2E3 are linked to several retinal disorders. Autosomal dominant mutations cause enhanced S‑cone syndrome (ESCS), a condition characterized by photoreceptor degeneration, impaired night vision, and an abnormal excess of S‑cone photoreceptors. Autosomal recessive mutations lead to complete congenital stationary night blindness and retinitis pigmentosa. These mutations typically involve missense substitutions in the DNA‑binding or ligand‑binding domains, disrupting normal transcriptional regulation.

At the molecular level, NR2E3 can homodimerize and heterodimerize with other nuclear receptors such as RXR. It binds to specific xenobiotic response elements in target gene promoters. Its activity is modulated by post‑translational modifications, including phosphorylation and sumoylation, which influence DNA binding affinity and transcriptional repression potency.

Because of its central role in photoreceptor biology, NR2E3 remains a focus of research aimed at understanding retinal development and developing gene‑based therapies for inherited retinal diseases.